| Dual roles of PARP-1 promote cancer growth and progression MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ... Cancer discovery 2 (12), 1134-1149, 2012 | 461 | 2012 |
| Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression K Yoshida, S Toden, P Ravindranathan, H Han, A Goel Carcinogenesis 38 (10), 1036-1046, 2017 | 195 | 2017 |
| Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer P Ravindranathan, TK Lee, L Yang, MM Centenera, L Butler, WD Tilley, ... Nature communications 4 (1), 1923, 2013 | 162 | 2013 |
| Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer S Wang, RK Kollipara, N Srivastava, R Li, P Ravindranathan, ... Proceedings of the National Academy of Sciences 111 (11), 4251-4256, 2014 | 154 | 2014 |
| Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1-and estrogen receptor-containing transcription complexes AR Daniel, AL Gaviglio, TP Knutson, JH Ostrander, AB D'Assoro, ... Oncogene 34 (4), 506-515, 2015 | 150 | 2015 |
| A patient‐derived explant (PDE) model of hormone‐dependent cancer MM Centenera, TE Hickey, S Jindal, NK Ryan, P Ravindranathan, ... Molecular oncology 12 (9), 1608-1622, 2018 | 102 | 2018 |
| Mouse spermatogenesis requires classical and nonclassical testosterone signaling C Toocheck, T Clister, J Shupe, C Crum, P Ravindranathan, TK Lee, ... Biology of Reproduction 94 (1), 11, 1-14, 2016 | 88 | 2016 |
| EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer LJ Brand, ME Olson, P Ravindranathan, H Guo, AM Kempema, ... Oncotarget 6 (6), 3811, 2015 | 81 | 2015 |
| Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer S Toden, P Ravindranathan, J Gu, J Cardenas, M Yuchang, A Goel Scientific reports 8 (1), 3335, 2018 | 69 | 2018 |
| A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer P Ravindranathan, D Pasham, U Balaji, J Cardenas, J Gu, S Toden, ... Scientific reports 8 (1), 13869, 2018 | 64 | 2018 |
| Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer L Yang, P Ravindranathan, M Ramanan, P Kapur, SR Hammes, JT Hsieh, ... Molecular endocrinology 26 (4), 550-561, 2012 | 56 | 2012 |
| Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer P Ravindranathan, D Pasham, U Balaji, J Cardenas, J Gu, S Toden, ... Carcinogenesis 39 (6), 767-777, 2018 | 50 | 2018 |
| Oligomeric proanthocyanidins (OPCs) from grape seed extract suppress the activity of ABC transporters in overcoming chemoresistance in colorectal cancer cells P Ravindranathan, D Pasham, A Goel Carcinogenesis 40 (3), 412-421, 2019 | 31 | 2019 |
| The social network of PELP1 and its implications in breast and prostate cancers VK Gonugunta, L Miao, GR Sareddy, P Ravindranathan, R Vadlamudi, ... Endocrine-related cancer 21 (4), T79-T86, 2014 | 26 | 2014 |
| Minireview: deciphering the cellular functions of PELP1 P Ravindranathan, CA Lange, GV Raj Molecular endocrinology 29 (9), 1222-1229, 2015 | 25 | 2015 |
| A Structure—Activity Relationship Study of Bis-Benzamides as Inhibitors of Androgen Receptor—Coactivator Interaction TK Lee, P Ravindranathan, R Sonavane, GV Raj, JM Ahn Molecules 24 (15), 2783, 2019 | 7 | 2019 |
| Global transcriptomic profiling reveals anticancer role of oligomeric proanthocyanidins from grape seeds in colorectal cancer P Ravindranathan, D Pasham, U Balaji, S Toden, A Goel Cancer Research 78 (13_Supplement), 2682-2682, 2018 | | 2018 |
| Targeting Androgen Signaling in Prostate Cancer PH Chung, P Ravindranathan, BA Gayed, GV Raj Gene Regulation, Epigenetics and Hormone Signaling, 399-416, 2017 | | 2017 |
| Predictive and prognostic biomarkers for next-generation hormonal agents in castration resistant prostate cancer M Gleave, AA Azad, J Bishop, M Brown, BS Carver, N Clarke, KN Chi, ... Medical Treatment of Urological Malignancies: International Consultation on …, 2015 | | 2015 |
| Rational targeting of the Androgen receptor interactome in prostate cancer P Ravindranathan, W Tilley, GV Raj Cancer Research 74 (19_Supplement), 4255-4255, 2014 | | 2014 |
Matthew SchiewerKimmel Cancer Center at Thomas Jefferson UniversityVerified email at jefferson.edu
